stockportfolio.pro
Stocks / CAH vs IDXX
CAH vs IDXX
Cardinal Health, Inc. and IDEXX Laboratories, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Cardinal Health, Inc. (CAH) | IDEXX Laboratories, Inc. (IDXX) | |
|---|---|---|
| Market cap | $49.8B | $45.7B |
| Revenue (latest FY) | $222.58B | $4.30B |
| Net income (latest FY) | $1.56B | $1.06B |
| Revenue growth (5y CAGR) | 7.8% | 9.7% |
| Net margin | 0.7% | 24.6% |
| Return on equity | -56.1% | 66.0% |
| P/E ratio | 32.5 | 42.6 |
| Dividend yield | 1.0% | — |
| Profitable years (of last 10) | 8 | 10 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open CAH — free Open IDXX — freeFrequently asked questions
Which is bigger, CAH or IDXX?
Cardinal Health, Inc. is larger by market capitalization — $49.8B versus $45.7B.
Which grows faster, CAH or IDXX?
Over the last five fiscal years, IDEXX Laboratories, Inc. grew revenue faster — 9.7%/yr versus 7.8%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.